ORBIMED ADVISORS LLC
SEC CIK 1055951 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ETRA | Electra Therapeutics, Inc. | Dir, 10% | 758.3K | $20.00M | — | 2 | 2026-09-21 | 2026-09-21 |
| BLSM | BlossomHill Therapeutics, Inc. | Dir | 2.09M | $10.00M | — | 2 | 2026-08-10 | 2026-08-10 |
| BRVE | Braveheart Bio, Inc. | Dir, 10% | 10.24M | $34.92M | — | 2 | 2026-08-07 | 2026-08-07 |
| SCTX | Scribe Therapeutics, Inc. | Dir | 348.8K | $15.00M | — | 2 | 2026-07-27 | 2026-07-27 |
| SION | Sionna Therapeutics, Inc. | Dir | 2.47M | — | $52.73M | 7 | 2025-11-24 | 2026-07-07 |
| ELVN | Enliven Therapeutics, Inc. | 10% | 6.56M | — | $51.68M | 2 | 2026-06-15 | 2026-06-22 |
| QTTB | Q32 Bio Inc. | Dir, 10% | 625.0K | $15.00M | — | 1 | 2026-05-28 | 2026-05-28 |
| PRLD | Prelude Therapeutics Inc | Dir, 10% | 1.13M | $12.50M | — | 1 | 2026-04-21 | 2026-04-21 |
| TRAW | Traws Pharma, Inc. | 10% | 1.20M | $998.2K | — | 1 | 2026-04-16 | 2026-04-16 |
| ACET | Adicet Bio, Inc. | Dir, 10% | 0 | $6.83M | $674.8K | 3 | 2023-06-27 | 2026-04-07 |
| PMVP | PMV Pharmaceuticals, Inc. | 10% | 5.98M | — | $900.0K | 1 | 2025-09-10 | 2025-09-10 |
| IMA | ImageneBio, Inc. | Dir | 287.9K | — | — | 2 | 2023-08-04 | 2025-07-25 |
| CRVS | Corvus Pharmaceuticals, Inc. | Dir, 10% | 7.17M | — | $4.89M | 2 | 2025-06-27 | 2025-06-27 |
| PASG | Passage BIO, Inc. | 10% | 6.28M | $1.26M | $498.1K | 7 | 2022-01-20 | 2025-06-24 |
| NPCE | NeuroPace Inc | 10% | 3.27M | — | $4.01M | 4 | 2024-04-19 | 2025-05-14 |
| IRON | Disc Medicine, Inc. | Dir, 10% | 482.3K | $2.50M | $310.5K | 2 | 2023-02-15 | 2025-03-24 |
| UPB | Upstream Bio, Inc. | Dir, 10% | 973.7K | $14.03M | — | 2 | 2024-10-15 | 2024-10-15 |
| MBX | MBX Biosciences, Inc. | Dir, 10% | 403.8K | $12.00M | — | 2 | 2024-09-16 | 2024-09-16 |
| TELA | TELA Bio, Inc. | 10% | 2.46M | — | $3.81M | 2 | 2023-04-19 | 2024-06-28 |
| DMRA | Damora Therapeutics, Inc. | 10% | 179.8K | — | $128.3K | 1 | 2023-04-13 | 2023-04-13 |
| CMPX | Compass Therapeutics, Inc. | Dir, 10% | 15.22M | $1.71M | — | 2 | 2022-05-11 | 2022-11-08 |
| XTNT | Xtant Medical Holdings, Inc. | Dir, 10% | 215.4K | — | — | 1 | 2022-08-15 | 2022-08-15 |
Transactions 51
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-09-23 17:29 | 2026-09-21 | ETRA | Electra Therapeutics, Inc. | ORBIMED ADVISORS LLC | Dir, 10% | C - Cnv Deriv | — | +5.55M | 758.3K | New | — |
| DMI | 2026-09-23 17:29 | 2026-09-21 | ETRA | Electra Therapeutics, Inc. | ORBIMED ADVISORS LLC | Dir, 10% | P - Purchase | $15.00 | +1.33M | 1.76M | +314% | +$20.00M |
| DMI | 2026-08-12 16:43 | 2026-08-10 | BLSM | BlossomHill Therapeutics, Inc. | ORBIMED ADVISORS LLC | Dir | C - Cnv Deriv | — | +2.09M | 2.09M | New | — |
| DI | 2026-08-12 16:43 | 2026-08-10 | BLSM | BlossomHill Therapeutics, Inc. | ORBIMED ADVISORS LLC | Dir | P - Purchase | $16.00 | +625.0K | 2.71M | +30% | +$10.00M |
| DI | 2026-08-11 17:27 | 2026-08-07 | BRVE | Braveheart Bio, Inc. | ORBIMED ADVISORS LLC | Dir, 10% | C - Cnv Deriv | — | +9.13M | 10.24M | +828% | — |
| DMI | 2026-08-11 17:27 | 2026-08-07 | BRVE | Braveheart Bio, Inc. | ORBIMED ADVISORS LLC | Dir, 10% | P - Purchase | $18.00 | +1.94M | 273.3K | New | +$34.92M |
| DI | 2026-07-29 18:47 | 2026-07-27 | SCTX | Scribe Therapeutics, Inc. | ORBIMED ADVISORS LLC | Dir | C - Cnv Deriv | — | +348.8K | 348.8K | New | — |
| DI | 2026-07-29 18:47 | 2026-07-27 | SCTX | Scribe Therapeutics, Inc. | ORBIMED ADVISORS LLC | Dir | P - Purchase | $15.00 | +1.00M | 1.35M | +287% | +$15.00M |
| TI | 2026-07-09 16:44 | 2026-07-07 | SION | Sionna Therapeutics, Inc. | ORBIMED ADVISORS LLC | Dir | S - Sale | $44.86 | -85.9K | 2.47M | -3% | -$3.85M |
| TI | 2026-07-02 16:42 | 2026-06-30 | SION | Sionna Therapeutics, Inc. | ORBIMED ADVISORS LLC | Dir | S - Sale | $45.50 | -115.8K | 2.56M | -4% | -$5.27M |
| MI | 2026-06-24 19:19 | 2026-06-22 | ELVN | Enliven Therapeutics, Inc. | ORBIMED ADVISORS LLC | 10% | S - Sale | $45.36 | -860.1K | 6.56M | -12% | -$39.01M |
| MI | 2026-06-17 19:45 | 2026-06-15 | ELVN | Enliven Therapeutics, Inc. | ORBIMED ADVISORS LLC | 10% | S - Sale | $45.02 | -281.4K | 7.39M | -4% | -$12.67M |
| MI | 2026-06-01 21:13 | 2026-05-28 | QTTB | Q32 Bio Inc. | ORBIMED ADVISORS LLC | Dir, 10% | P - Purchase | $8.00 | +1.88M | 625.0K | New | +$15.00M |
| TI | 2026-05-29 20:57 | 2026-05-27 | SION | Sionna Therapeutics, Inc. | ORBIMED ADVISORS LLC | Dir | S - Sale | $44.49 | -101 | 2.67M | -0.0% | -$4,493 |
| MTI | 2026-05-11 18:58 | 2026-05-07+ | SION | Sionna Therapeutics, Inc. | ORBIMED ADVISORS LLC | Dir | S - Sale | $45.62 | -293.0K | 2.67M | -10% | -$13.36M |
| DI | 2026-04-28 21:41 | 2026-04-16 | TRAW | Traws Pharma, Inc. | ORBIMED ADVISORS LLC | 10% | P - Purchase | $1.67 | +597.7K | 1.20M | +99% | +$998.2K |
| MI | 2026-04-23 18:48 | 2026-04-21 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Dir, 10% | P - Purchase | $4.44 | +2.82M | 1.13M | New | +$12.50M |
| MTI | 2026-04-21 20:40 | 2026-04-17+ | SION | Sionna Therapeutics, Inc. | ORBIMED ADVISORS LLC | Dir | S - Sale | $44.67 | -55.3K | 2.96M | -2% | -$2.47M |
| MTI | 2026-04-16 19:03 | 2026-04-14+ | SION | Sionna Therapeutics, Inc. | ORBIMED ADVISORS LLC | Dir | S - Sale | $44.94 | -510.6K | 3.02M | -14% | -$22.95M |
| MI | 2026-04-09 17:38 | 2026-04-07+ | ACET | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | 10% | S - Sale | $6.45 | -104.7K | 0 | -100% | -$674.8K |
| MI | 2025-11-26 | 2025-11-24+ | SION | Sionna Therapeutics, Inc. | ORBIMED ADVISORS LLC | Dir | S - Sale | $44.55 | -108.1K | 3.60M | -3% | -$4.81M |
| MI | 2025-10-10 | 2025-10-08 | ACET | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | 10% | P - Purchase | $1.00 | +5.00M | 4.49M | New | +$5.00M |
| I | 2025-09-12 | 2025-09-10 | PMVP | PMV Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | 10% | S - Sale | $1.80 | -500.0K | 5.98M | -8% | -$900.0K |
| I | 2025-07-30 | 2025-07-25 | IMA | ImageneBio, Inc. | ORBIMED ADVISORS LLC | Dir | A - Grant | $2.49 | +83.6K | 287.9K | +41% | +$208.2K |
| DI | 2025-07-01 | 2025-06-27 | CRVS | Corvus Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Dir, 10% | S - Sale+OE | $4.16 | -1.18M | 7.17M | -14% | -$4.89M |
| DI | 2025-07-01 | 2025-06-27 | CRVS | Corvus Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Dir, 10% | X - OptEx | $3.50 | +1.40M | 8.34M | +20% | +$4.89M |
| MI | 2025-06-26 | 2025-06-24+ | PASG | Passage BIO, Inc. | ORBIMED ADVISORS LLC | 10% | S - Sale | $0.3379 | -583.7K | 6.28M | -9% | -$197.2K |
| MI | 2025-05-16 | 2025-05-14 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | S - Sale | $15.85 | -168.1K | 3.27M | -5% | -$2.67M |
| MI | 2025-04-24 | 2025-04-22+ | PASG | Passage BIO, Inc. | ORBIMED ADVISORS LLC | 10% | S - Sale | $0.3342 | -235.6K | 6.81M | -3% | -$78.7K |
| MI | 2025-03-26 | 2025-03-24 | IRON | Disc Medicine, Inc. | ORBIMED ADVISORS LLC | Dir | S - Sale | $54.11 | -5,738 | 482.3K | -1% | -$310.5K |
| MI | 2025-01-14 | 2025-01-10+ | PASG | Passage BIO, Inc. | ORBIMED ADVISORS LLC | 10% | S - Sale | $0.6371 | -223.2K | 7.03M | -3% | -$142.2K |
| MI | 2024-12-11 | 2024-12-09+ | PASG | Passage BIO, Inc. | ORBIMED ADVISORS LLC | 10% | S - Sale | $0.8348 | -62.3K | 7.64M | -0.8% | -$52.0K |
| DMI | 2024-10-17 | 2024-10-15 | UPB | Upstream Bio, Inc. | ORBIMED ADVISORS LLC | Dir, 10% | C - Cnv Deriv | — | +3.61M | 973.7K | New | — |
| DMI | 2024-10-17 | 2024-10-15 | UPB | Upstream Bio, Inc. | ORBIMED ADVISORS LLC | Dir, 10% | P - Purchase | $17.00 | +825.0K | 4.55M | +22% | +$14.03M |
| I | 2024-09-23 | 2024-09-19 | PASG | Passage BIO, Inc. | ORBIMED ADVISORS LLC | 10% | S - Sale | $0.71 | -39.3K | 7.79M | -0.5% | -$27.9K |
| DMI | 2024-09-17 | 2024-09-16 | MBX | MBX Biosciences, Inc. | ORBIMED ADVISORS LLC | Dir, 10% | C - Cnv Deriv | — | +3.06M | 403.8K | New | — |
| DMI | 2024-09-17 | 2024-09-16 | MBX | MBX Biosciences, Inc. | ORBIMED ADVISORS LLC | Dir, 10% | P - Purchase | $16.00 | +750.0K | 653.8K | New | +$12.00M |
| MI | 2024-07-02 | 2024-06-28+ | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% | S - Sale | $4.72 | -428.3K | 2.46M | -15% | -$2.02M |
| MI | 2024-05-03 | 2024-05-01+ | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | S - Sale | $14.02 | -29.2K | 3.41M | -0.9% | -$409.4K |
| I | 2024-04-26 | 2024-04-24 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | S - Sale | $14.06 | -1,781 | 3.44M | -0.1% | -$25.0K |
| MI | 2024-04-23 | 2024-04-19+ | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | S - Sale | $14.12 | -64.7K | 3.48M | -2% | -$913.1K |
| DAI | 2023-09-21 | 2023-08-04 | IMA | ImageneBio, Inc. | ORBIMED ADVISORS LLC | Dir | A - Grant | — | +153.1K | 5.58M | +3% | — |
| MI | 2023-06-29 | 2023-06-27+ | PASG | Passage BIO, Inc. | ORBIMED ADVISORS LLC | 10% | P - Purchase | $0.84 | +1.19M | 8.03M | +17% | +$1.00M |
| MI | 2023-06-29 | 2023-06-27 | ACET | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | Dir, 10% | P - Purchase | $2.09 | +875.0K | 1.03M | +572% | +$1.83M |
| MI | 2023-04-21 | 2023-04-19+ | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% | S - Sale | $9.34 | -192.0K | 2.89M | -6% | -$1.79M |
| MI | 2023-04-17 | 2023-04-13+ | DMRA | Damora Therapeutics, Inc. | ORBIMED ADVISORS LLC | 10% | S - Sale | $1.87 | -68.5K | 179.8K | -28% | -$128.3K |
| MI | 2023-02-17 | 2023-02-15 | IRON | Disc Medicine, Inc. | ORBIMED ADVISORS LLC | Dir, 10% | P - Purchase | $23.00 | +108.7K | 773.6K | +16% | +$2.50M |
| I | 2022-11-10 | 2022-11-08 | CMPX | Compass Therapeutics, Inc. | ORBIMED ADVISORS LLC | Dir, 10% | P - Purchase | $3.21 | +402.0K | 15.22M | +3% | +$1.29M |
| MI | 2022-08-17 | 2022-08-15 | XTNT | Xtant Medical Holdings, Inc. | ORBIMED ADVISORS LLC | Dir, 10% | J - Other | $0.00 | +430.8K | 215.4K | New | $0 |
| MI | 2022-05-13 | 2022-05-11+ | CMPX | Compass Therapeutics, Inc. | ORBIMED ADVISORS LLC | Dir, 10% | P - Purchase | $2.18 | +192.5K | 14.82M | +1% | +$420.5K |
| AI | 2022-05-05 | 2022-01-20 | PASG | Passage BIO, Inc. | ORBIMED ADVISORS LLC | 10% | P - Purchase | $5.00 | +50.8K | 6.32M | +0.8% | +$254.0K |